Orchid Pharma Quarterly Results for Trading Insights
ORCHPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-6 Cr
QSept 2025
Orchid Pharma Quarterly Results Key Highlights
- Revenue of ₹204 Cr in Sept 2025 (-15.4% vs Mar 2025, -11.3% vs Sept 2024)
- Net Profit of ₹-6 Cr in Sept 2025 (-127.3% vs Mar 2025, -122.2% vs Sept 2024)
- EBITDA of ₹9 Cr in Sept 2025 (-71.9% vs Mar 2025)
- Operating Margin of -1.0% in Sept 2025 (-13.0pp vs Mar 2025)
- Earnings Per Share of ₹-1.13 in Sept 2025 (-125.7% vs Mar 2025)
Orchid Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 204 | 241 | 184 | 230 | 231 | -15.4% | -11.3% |
| Net Profit (₹ Cr) | -6 | 22 | 15 | 27 | 33 | - | - |
| EBITDA (₹ Cr) | 9 | 32 | 26 | 38 | 42 | - | - |
| EPS (₹) | -1.13 | 4.40 | 2.94 | 5.37 | 6.81 | - | - |
| Operating Margin (%) | -1.0% | 12.0% | 8.0% | 14.0% | 13.0% | - | - |
Orchid Pharma Share Price Trend Around Quarterly Results
Visualize Orchid Pharma's 1-year price movement across quarterly results — ideal for logging trades in Orchid Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Orchid Pharma
Additional stock information and data for ORCHPHARMA
Revenue Trend (₹ Cr)
Sept 2024
230
Jun 2025
184
Mar 2025
241
Sept 2025
204
Net Profit Trend (₹ Cr)
Sept 2024
27
Jun 2025
15
Mar 2025
22
Sept 2025
-6
Operating Margin Trend (%)
Sept 2024
14.0%
Jun 2025
8.0%
Mar 2025
12.0%
Sept 2025
-1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Orchid Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores